EXHIBIT 1Schedule 13d Agreement • August 15th, 2002 • Tisch Daniel R • Services-commercial physical & biological research
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, par value $0.001 per share, of Incyte Genomics, Inc., and such other amendments as may be filed by them hereafter, are being filed with the Securities and Exchange Commission on behalf of each of them.
